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Abstract: Previous studies of recreational waters and blue-green algae supplements (BGAS)
demonstrated co-occurrence of Aphanizomenon flos-aquae (AFA) and cyanotoxins, presenting exposure
risk. The authors conducted a systematic literature review using a GRADE PRISMA-p 27-item
checklist to assess the evidence for toxigenicity of AFA in both fresh waters and BGAS. Studies have
shown AFA can produce significant levels of cylindrospermopsin and saxitoxin in fresh waters.
Toxicity studies evaluating AFA-based BGAS found some products carried the mcyE gene and
tested positive for microcystins at levels ≤ 1 µg microcystin (MC)-LR equivalents/g dry weight.
Further analysis discovered BGAS samples had cyanotoxins levels exceeding tolerable daily intake
values. There is evidence that Aphanizomenon spp. are toxin producers and AFA has toxigenic
genes such as mcyE that could lead to the production of MC under the right environmental
conditions. Regardless of this ability, AFA commonly co-occur with known MC producers, which may
contaminate BGAS. Toxin production by cyanobacteria is a health concern for both recreational
water users and BGAS consumers. Recommendations include: limit harvesting of AFA to months
when toxicity is lowest, include AFA in cell counts during visible blooms, and properly identify
cyanobacteria species using 16S rRNA methods when toxicity levels are higher than advisory levels.
Keywords: Aphanizomenon flos-aquae; blue-green algae supplements; cyanotoxins; microcystin;
cylindrospermopsin; saxitoxin
Key Contribution: This manuscript informs the debate over toxigenicity of Aphanizomenon flos-aquae
as it relates to exposure in recreational fresh waters and consumption of relevant blue-green
algae supplements.
1. Introduction
Cyanobacteria, also known as blue-green algae, are photosynthetic bacteria that occur in many
fresh and salt water environments around the world. Some cyanobacteria species are toxigenic;
they have the potential to produce toxins that can harm people, pets and wildlife. Aphanizomenon
flos-aquae (AFA) is naturally present in fresh-water sources and has been harvested as dietary
blue-green algae supplements (BGAS) in the U.S. since the 1980s [1,2]. AFA is one of the most
common species of cyanobacteria collected from the natural environment. In freshwater environments,
several cyanobacteria species including Aphanizomenon spp. form the most common and noxious
type of harmful cyanobacteria blooms (CyanoHABs), which have potentially dire consequences for
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environmental and human health [3,4]. The potential danger that exposure to cyanotoxins presents is
widely known [2,5], and has been estimated to cause between 50,000 to 500,000 human intoxications
per year from consumption of finfish and shellfish [6]. While the liver is the primary target organ
of microcystins (MCs), other organs can be affected as well [7]. Previous studies have shown effects
on the heart, nervous system, kidneys, and GI tract [8]. Very few earlier studies addressed the
variability of toxin content in BGAS, although this knowledge would have been important for risk
assessments. Long-term consumption of BGAS containing harmful cyanotoxins is cause for public
health concerns as they are widely available, labeled as safe products and promoted as beneficial for
health. In addition, a plethora of fatalities and severe illness/injury have been recorded worldwide
in pets, livestock, birds, wildlife and fish [9–12]. Most cyanotoxin poisonings have occurred when
animals drink cyanobacterial-laden freshwater, but other aquatic animals, including fish and shellfish,
are also affected [13]. These effects include diarrheal illness, acute liver damage, and even more serious
and potentially fatal neurotoxic outcomes.
Cyanotoxin guidelines were established by the World Health Organization (WHO) in 1999 [5].
Work is ongoing to determine appropriate lethal dose for 50 percent of the test population (LD50)
and tolerable daily intake (TDI), or thresholds for daily reference doses (RfD). Under the Clean Water
Act (CWA) 304(a) the Environmental Protection Agency (EPA) recommended a threshold for RfD
concentrations of cyanotoxins to protect human health while swimming or participating in other
recreational activities in and on the water [14]. States can adopt the EPA criteria into their water
quality standards and use these same threshold values as the basis of swimming advisories for public
notification purposes at beaches [14]. States may also use the proposed EPA RfD values when adopting
new or revised water quality standards (WQS). If adopted as WQS and approved by the EPA under
CWA 303(c), the WQS could be used for all CWA purposes. The EPA has also noted that currently,
“available data are insufficient to develop quantitative recreational values for cyanobacterial cell
density related to health outcomes” [14]. The epidemiologic associations between cell density and
specific health outcomes described in the literature are not consistent [14]. In addition, epidemiologic
studies addressing species and strains of cyanobacteria and cell densities associated with significant
health effects do not provide sufficient information to determine a consistent association between
cyanobacteria cell counts and adverse health outcomes [14].
Because of incidents attributed to toxic CyanoHABs, the WHO and the EPA recommended
that risk assessment plans and safety levels include cyanobacteria as an environmental parameter
to be monitored and assessed. Swimmers can involuntarily swallow water while swimming,
and harm from ingestion of recreational water is comparable to that of drinking water with the
same toxin content [5]. For recreational water users with whole-body contact, a swimmer can
expect to ingest 100–200 mL of water in one session, with sailboard riders and water skiers
ingesting more depending upon age and length of exposure [5]. AFA is reported to be capable
of producing anatoxin-a (ANTX), cylindrospermopsin (CYN), microcystins (MCs), and the paralytic
shellfish poison toxins (PSP toxins), saxitoxins (STXs), though there have been conflicting reports
and varying advisory levels among scientists and health departments [5,13–15]. In addition,
laboratory studies with pure strains of cyanobacteria have found that environmental factors can
induce changes in toxicity or toxin concentration [5]. The factors that control the growth and
toxin content of individual strains are unknown, but the regulation of cyanotoxin production is
a critical area for further study and understanding [5]. Most existing studies say that cyanobacteria
produce the most toxins under favorable environmental conditions for growth, such as temperature,
light, and pH levels [4,5]. Although different cyanobacteria species have differing light and temperature
requirements, all cyanobacteria strains produce the most toxins when grown under optimal light
conditions [5]. Traditionally we have seen seasonal patterns of CyanoHABs with the majority reported
during the warmer summer months [14]. This may lead to recommendations for seasonal harvesting of
AFA when MC concentration would be lowest, and for increased testing and warnings for recreational
use and seafood consumption during times of high MC levels.
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The aim of this systematic review is to determine the strength of evidence for the toxigenicity of




Some species of cyanobacteria are considered toxigenic, meaning they carry the genes responsible
for producing various toxins that are classified by mode of action into hepatotoxins (MC, CYN),
neurotoxins (ANTX, STX), and skin irritants [16]. Several factors determine toxin production by
cyanobacteria, including trophic, genetic, hydrological, environmental, and seasonal patterns [3,14].
A level of 100,000 cyanobacterial cells/mL (which is equivalent to approximately 50 mg chlorophyll-a/L
if cyanobacteria dominate) is a guideline value for a moderate health alert in recreational waters [5].
Aphanizomenon spp. are known to produce a variety of cyanotoxins, including ANTX, CYN and
STX [17–19]. Aphanizomenon spp. produce toxins in eutrophic conditions; studies suggest that nitrogen
limitation may increase the extracellular release of toxin in CYN-producing cultures. The release of
toxins through the cell membrane has been linked to NorM MATE proteins encoded by genes cyrK
(for CYN toxins) [15,19,20] and sxtM (for STXs) [20,21]. Extracellular toxins are directly bioavailable
and in direct contact with aquatic organisms and water users during bloom development and even
after bloom dissipation. Some of these cyanotoxins have slow natural photo- and biodegradation
(particularly CYN) [20] and need more monitoring for ecological and health risk assessments in waters
commonly affected by Aphanizomenon spp.
2.1.1. Anatoxin-a
ANTX is a naturally occurring organophosphate. Toxicity of ANTX has been well documented
since the 1960s [22]. It is an acute neurotoxin that has been shown to be toxigenic to both animals and
humans. Uncertainty exists about the effects of ingestion of ANTX at low levels over extended periods
of time [23]. The LD50 of ANTX is 200–250 µg/kg body weight in rats [24,25]. ANTX binds to nicotinic
acetylcholine receptors where it mimics the natural ligand, acetylcholine [26], binding at 20 times
higher affinity than acetylcholine. Normally, binding of acetylcholine to its receptor in neuronal
membranes induces a conformation change in the receptor which results in the opening of an ion
channel in the membrane, allowing calcium and/or sodium ions to move across the lipid bilayer [22].
This “depolarization” of the membrane allows for muscle contraction. Normally acetylcholinesterase
quickly degrades acetylcholine, halting the activity. ANTX produces the same effect when it binds to
the acetylcholine receptor, except that the binding is irreversible. After continuous stimulation of the
neuromuscular junction a desensitization or “block” may follow, resulting in death due to respiratory
paralysis [22]. Symptoms of ANTX ingestion include muscle tremors (involuntary muscle contractions
or fasciculations) that can often be seen under the skin, followed by decreased movement, rigidity,
exaggerated breathing, cyanosis, convulsions, respiratory paralysis and death [26]. Depending on the
dose and species exposed, death can occur anywhere between a few minutes to 3 h. In some species
ANTX exposure can cause significant effects on blood pressure, heart rate, and acidosis [27]. There are
no human health standards for ANTX. The highest no-observed-adverse-effect level in mice (NOAEL)
is 2.5 mg/kg-day [2]. While ANTX does not have a NOAEL for humans, researchers have developed
a guideline value for ANTX in drinking water of 1 µg/L based on mice studies that would offer an
adequate margin of safety for humans [23].
2.1.2. Cylindrospermopsin
CYN is a naturally occurring liver toxin that is found typically in warm tropical waters but, has a
presence worldwide. CYN is found in cyanobacteria such as Cylindrospermopsis raciborskii detected in
Australia, Hungary [28], and the U.S. [29]; Umezakia natans in Japan [30]; Anabaena bergii in Israel [31];
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Raphidopsis curvata in China [32]; and Aphanizomenon ovalisporium in Australia and Israel [31,33]. CYN is
a potent inhibitor of protein synthesis [34]. In addition, studies have shown that this toxin is extremely
stable. While CYN rapidly degrades in sunlight, it is resistant to degradation by temperature or
pH [2]. P-450 metabolism is thought to be important in the toxicity of CYN. Studies by Runnegar et al.
indicate that the toxicity of CYN may be due to the production of a CYN metabolite since toxicity in
the presence of P-450 inhibitors is greatly reduced [35]. CYN has also recently been reported to be a
suspect carcinogen, as it has been shown to be both mutagenic and cytotoxic [36]. The LD50 (oral) in
mice was determined to be approximately 4–6 mg/kg [22]. The EPA also evaluated the health effects
of CYN and derived an RfD in its 2015 ‘Health Effects Support Document for the Cyanobacterial
Toxin Cylindrospermopsin’ [2]. The kidneys and liver appear to be the primary target organs for CYN
toxicity. A critical study for the derivation of the CYN RfD was conducted by Humpage & Falconer
(2003) based on drinking water exposure in mice [37]. The critical effect of cyanotoxins noted by the
EPA was kidney damage, including increased kidney weight and decreased urinary protein [2].
2.1.3. Microcystins
MCs are a class of cyclic peptides, typically containing seven amino acids. Those found
in freshwater are predominantly produced by species of Microcystis, Planktothrix (Oscillatoria),
Anabaenopsis, Cylindrospermopsis and Aphanizomenon [38]. This group of natural toxins include MCs and
CYN [38]. MCs are hepatotoxins and once ingested, travel through the body to the liver, where they
are stored. MC-LR is the most common MC and is an extremely acute toxin. The LD50 by the
intraperitoneal route is approximately 25–150 µg/kg of body weight in mice; the oral LD50 (by gavage)
is 5000 µg/kg of body weight in mice, and higher in rats [39]. With an estimated 100 MC congeners
identified and named according to variable amino acids positions, complete evaluation of supplements
or cyanobacterial material for all congeners is not feasible [40]. The provisional WHO guideline of
1 µg/L MC-LR is used if local health authorities suspect a risk to human health [4,5,16]. Because
of repeated MC findings in BGAS, many countries have elected to develop regulatory limits for the
amount of MC in these products, including businesses harvesting and selling AFA [41]. The EPA
evaluated the health effects of MCs and derived a RfD in the 2015 document “Health Effects Support
Document for the Cyanobacterial Toxin Microcystins”. The derivation of the MCs RfD was established
by Heinze et al. in 1999, based on rat exposure to MC-LR in drinking water [40]. It is well known that
MC-LR is the most toxic form of an estimated ~100 known congeners of MC [14,42]; therefore, the EPA
established an RfD for MC-LR and used it as a surrogate value for the other ~100 MC congeners.
2.1.4. Saxitoxin
Another toxin produced by AFA is saxitoxin (STX), a paralytic shellfish poison (PSP) found
in both marine and freshwater environments. The term saxitoxin can also refer to a class of more
than 50 structurally related neurotoxins (known collectively as “saxitoxins” or STXs). Humans and
other animals are commonly poisoned by STXs after they are taken up by filter-feeding bivalves and
crustaceans, which ingest and concentrate the toxin within their tissues and organs [4]. STX-related
poisonings are well known in Oregon, Washington, California, Alaska and many of the New England
states [5,14]. Worldwide STXs have been documented in Australia, New Zealand, South Africa, China,
Thailand, Japan and coastal areas of Western Europe. In recent years there appears to be an increase in
STX intoxications. However, it is unknown whether this is a true increase in frequency, influenced
by warming climatic patterns or simply a reflection of increased awareness or improved methods
of detection. STXs exert their toxic effects by binding with high affinity to voltage-gated sodium
channels. This binding blocks the passage of sodium ions across biological membranes resulting in
a “blockade” of nerve signal transmission. STX is also capable of interfering with potassium and
calcium-mediated ion channels. In the case of potassium channels, the STX effect is slightly different.
Instead of blocking the potassium channel outright, it binds at the channel site, requiring stronger
membrane depolarization to open the channel [43]. This results in an overall reduction of potassium
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conductance across membranes. STX acts on calcium channels in a manner similar to its action on
sodium channels, although its ability to block calcium channels is not as efficient [43]. STX is fatal to
humans even in very low doses. STX is also capable of entering the human body via a cut or other
open wound, and the predicted human LD50 based on previous mice studies, via this route of exposure
has been estimated to be 50 µg/kg body weight [5,14]. Currently the acute RfD, used in place of the
NOAEL, is 0.5 µg STX equivalent/kg-day [44]. Humans develop a variety of symptoms, ranging from
slight tingling or numbness of the face and extremities, to complete respiratory paralysis. Neurological
symptoms present themselves shortly after ingestion [45].
2.2. Fresh Water
AFA is naturally present in freshwater sources [14]. CyanoHABs occur during optimal
environmental conditions for cyanobacterial growth, including warm water (temperatures between
50–86◦F), phosphorus concentrations greater than 30 µg/L, and high nitrogen content [4].
These conditions are often found during water pollution events, such as runoff from agricultural
operations, or golf course or residential chemical pollution. During CyanoHABs many species
of cyanobacteria produce toxins, which can be lethal or extremely harmful to both humans and
animals, even at very low concentrations [46]. Cyanotoxins are toxic substances released by certain
species of both marine and freshwater cyanobacteria during CyanoHABs, which are characterized by
rapid, unchecked growth of cyanobacteria promoted by the presence or sudden addition of nutrients
(especially nitrogen and phosphorus) into waters [14].
Throughout the literature AFA has demonstrated the ability to produce ATX, CYN, MC, and STXs
under certain conditions and in certain geographical areas. Overall the Aphanizomenon spp. show
evidence for moderate to high toxin production particularly with MCs, CYN (11–41% of total toxins,
up to 58–63% under certain conditions), ATX (7–47% of total toxins), and STXs (7–35% of total
toxins) [15,17]. While it is generally accepted that the Aphanizomenon spp. carry toxigenic genes
and produce ATX, CYN, MCs and STXs in varying degrees, uncertainty exists over whether AFA
has the genes for toxigenicity and if it does, whether it produces toxins in differing environmental
conditions. In 2015, genome analysis by Šulcius et al. revealed the presence of non-coding sequences
belonging to ANTX gene cluster that indicates AFA may have contained genes responsible for the
production of cyanotoxins [47]. While the non-coding genes may have been present, the two AFA
strains (2012/KM1/D3 and 2012/KM1/C4) that were isolated from bloom samples obtained from the
Curonian Lagoon did not produce any cyanotoxins [47]. Although high concentrations of MC toxins
were found in an oligo-mesotrophic lake in the Baltic Lake District, Germany, researchers discovered
that the MCs were not produced by the dominant cyanobacteria present (Dolichospermum circinale and
AFA) but by small numbers of Microcystis cf. aeruginosa and Planktothrix rubescens that co-habited the
blooms sampled [48]. AFA was tested with HEPF/HEPR primers, but without any amplification for
the mcyE gene responsible for MC toxin production [48]. Since AFA was responsible for 80% of the
bloom’s total biomass [48], contamination with Microcystis aeruginosa is likely. This cyanobacterial
co-occurrence also supports findings by Palus et al. in 2007, where cyanobacterial blooms were found
to be most intense between August and September, producing the highest concentrations of MC
toxins seen in the study [46]. Microcystis aeruginosa and AFA were the most dominant cyanobacteria
present within the blooms during periods of high MC concentration [46], making determination of the
cyanobacteria responsible for the MC production more difficult.
More direct evidence for AFA toxigenicity was found in the following studies. In 2007 Fastner
et al. detected measurable amounts of CYN toxin in 21 German lakes with high concentrations
of Aphanizomenon spp. [28,49]. CYN was detected in 19 of the 21 lakes at concentrations ranging
from 0.002–0.484 µg/L (phytoplankton + suspended particles) and 0.08–11.75 µg/L dissolved in
water [28]. The maximum CYN measured in a total sample of water was 12.1 µg/L [28]. Aphanizomenon
gracile is highly correlated with CYN concentrations in the lakes and was suspected to be the major
producer of the detected CYN toxin [49], and may have led to potential contamination. In 2006
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Preussel et al. identified three isolates of AFA from two German lakes, which were found to produce
large amounts of CYN [17]. This was considered the first report of CYN in AFA strains [17].
CYN-synthesis of the strains was shown both by liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis and detection of PCR products of gene fragments [17]. The strains contained CYN
in the range of 2.3–6.6 mg/g of cellular dry weight [17]. In 2007 Faster et al. also confirmed that AFA
was a CYN-producing species, which often inhabits water bodies in temperate regions such as Germany
and Portugal [17,28,50]. A risk assessment is recommended to confirm findings in geographic locations,
suggesting that toxigenicity may vary by region [28]. Aphanizomenon var klebahnii was identified in 2009
in the Czech Republic as a potential producer of CYN toxins [51]. ANTX was also listed as a toxin
produced by AFA, found in flamingos in Lakes Bogoria and Nakuru in Kenya. [1,52]. The birds were
observed staggering and convulsing prior to death, and post-mortem studies found ANTX levels in the
liver capable of causing death at 1.06–5.82 µg/L fresh weight [53]. In addition to ANTX, MC-LR was
observed from 0.21 to 0.93 µg/L fresh weight within the bird livers post-mortem [53].
In addition to CYN and ANTX, there was evidence of STX when AFA was the dominant species
in the Montargil Reservoir, Portugal [54]. To confirm the production of neurotoxins, a strain of AFA
was isolated and established in culture and confirmed by high performance liquid chromatography
with post column fluorescence derivatization HPLC-FLD [54]. A study in 1986 similarly found
that AFA (NH-5) may produce neo-saxitoxin and saxitoxin, which was confirmed with thin-layer
chromatography and HPLC [53]. A 2001 study by Ferreira et al. also detected STX toxins in cultures of
AFA, isolated from the Crestuma-Lever Reservoir, using high performance liquid chromatography
(HPLC) [53]. This finding was supported by claims from Liu et al. in 2006 that AFA has been reported
in several countries to produce STXs and associated toxic effects [8]. Acute toxicity testing was
performed by mouse bioassay using extracts from the lyophilized material and clear symptoms of
STX intoxication were observed [8]. High performance liquid chromatography with post column
fluorescence derivatization (HPLC-FLD) and liquid chromatographic mass spectrometry technique
(LC-MS) analysis of extracts from cultured material demonstrated that STXs were produced by AFA
blooms in China [8]. This was the first study reporting chemically and toxicologically confirmed STXs
related to AFA in China [8]. Gkelis et al. identified AFA and C. raciborskii as potential producers of
STX, while confirming A. gracile did, in fact, produce STX [55]. It was also noted that the STX gene
cluster may vary biogeographically [55].
2.3. Dietary Supplements
Dietary supplements are largely self-regulated, although there are some safeguards in place
following the passage of the 1994 Dietary Supplement Health and Education Act (DSHEA) by the
United States Congress and its implementation by the Food and Drug Administration (FDA) [9]. In the
United States, the FDA has determined that AFA is a dietary supplement; therefore, it is not subject to
regulation as a drug, provided that the health benefits claimed by the manufacturer do not include the
cure or treatment of a specific disease such as depression or cancer [41].
The harvesting of cyanobacteria for production as dietary supplements has recently come under
scrutiny, as the production of these BGAS suffer from less strict quality controls than other food
products or pharmaceuticals. In addition, BGAS are marketed internationally and sold widely over
the counter and via the Internet. Although insufficient evidence exists, BGAS are reported to have
beneficial health effects including weight loss, increasing alertness and energy, and mood elevation for
people suffering from depression [2]. In children, they have been used as an alternative, natural therapy
to treat attention deficit hyperactivity disorders (ADHD) [2]. Although AFA-based BGAS have
generally been found to be non-toxic, the methods of cultivation in natural waters with inadequate
quality controls allows for contamination by other toxigenic species. AFA is primarily harvested
from Upper Klamath Lake in Oregon, USA where harvesting for supplement use started in the
1980’s. Other cyanobacteria species have been found to contaminate the products, since the AFA is
harvested from the natural environment. As a potential consequence of contamination, the presence
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of microcystins (MCs) and alkaloid cyanotoxins have been found in BGAS [56]. Studies have found
BGAS contaminated with MCs ranging from 1 µg/g up to 35 µg/g [57]. It is uncertain whether AFA
or contamination by other species of cyanobacteria is the source of the MC toxins.
For nearly 30 years, AFA has been harvested for blue-green algae supplements and constitutes a
significant portion of the health food supplement industry in North America [41]. AFA is primarily
harvested from cyanobacteria collected from Upper Klamath Lake in Oregon to produce BGAS [10,58].
In southern Oregon, growth of Microcystis aeruginosa is a regular occurrence together in blooms with
AFA [10]. Because M. aeruginosa regularly coexists with AFA it can be collected inadvertently during
the harvesting process, resulting in MC contamination of BGAS [10]. In 1996, in response to bloom
advisories and BGAS consumer concern, the Oregon Health Authority (OHA, then known as Oregon
Health Division) and the Oregon Department of Agriculture (ODA) established a regulatory limit of
1 µg/g for MCs in BGAS and tested BGAS products for the presence of MCs [10]. MCs were detected
in 85 of 87 samples tested, with 63 samples (72%) containing concentrations greater than the regulatory
limit of 1 µg/g. HPLC and ELISA toxin detection methods identified MC-LR as the predominant
congener within the BGAS [10].
Saker et al. (2007) supports the findings that many AFA-based BGAS may be contaminated with
MC-producing strains of Microcystis spp., and recommends that genetic testing be done to identify the
organism responsible for MC production [59]. Previous studies of AFA samples have relied on the
ELISA assay, which does not give information on the various chemical forms of MC [59]. Although the
health benefits of BGAS are promoted, there are a growing number of studies showing the presence of
toxins, some of which (for example MCs) are known to adversely affect human health [59]. In 2012,
Heussner et al. analyzed 13 commercially available BGAS in Germany for the presence of cyanotoxins.
All samples were analyzed and confirmed by PCR for the presence of the mcyE gene, a part of the
MC and nodularin gene cluster [11]. Of all products tested, ten consisted of AFA, five of Spirulina
platensis, and three of Chlorella pyrenoidosa [59]. Spirulina spp. are generally regarded as safe within
the BGAS industry as of this time [11]. Only AFA BGAS products tested positive for MCs as well as the
presence of the mcyE gene [11]. In 2015, a confirmed case of MC poisoning in a dog was documented
following the consumption of a BGAS containing organic AFA daily for just 3 weeks [9]. While several
brands of supplements of AFA have been found in the past to contain ANTX and its congeners [60,61],
neither ANTX nor CYN were found in any of the supplements in the 2012 study. All products
containing AFA tested positive for MCs at levels≤ 1 µg MC-LR equivalents/g dry weight [11]. In 2017,
Roy-Lachapell found that out of the 18 BGAS products analyzed, 8 contained cyanotoxins at levels
exceeding the tolerable daily intake values [56]. Toxic strains of AFA may be found occasionally in
some supplements, and have been reported to produce STX and ANTX toxins [56]. Some strains of
AFA are known to produce STX and beta-methylamino-L-alanine (BMAA) [56]. Dietary supplements
containing AFA had total MC toxin contents of between 0.8 and 8.2 µg/g [56].
3. Discussion
Cyanotoxin advisories and guideline values vary from state to state, and not all states have
advisory and guideline values. To date, fifteen states have included recreational guideline values for
cyanotoxins as part of their response protocol. The EPA currently lists Oregon’s options for recreational
water guidance/action level as public health advisory over >100,000 cells/mL of “toxigenic species”,
or >40,000 cells/mL of Microcystis or Planktothrix, and toxin testing for MC >10 µg/L, ANTX >20 µg/L,
CYN >6 µg/L, and STX >100 µg/L [14]. Currently, for the purpose of issuing public health advisories,
Oregon Health Authority excludes AFA from calculation of combined cell counts of toxigenic species.
Other states include all Aphanizomenon spp. in their list of potentially toxic cyanobacteria, e.g., toxigenic
taxa include Anabaena, Microcystis, Planktothrix, Nostoc, Coelosphaerium, Anabaenopsis, Aphanizomenon,
Gloeotrichia, Woronichinia, Oscillatoria, and Lyngbya [4].
There is evidence to support Aphanizomenon spp. as a known toxin producer specifically for
cyanotoxins: CYN (11–41%, up to 58–63% under certain conditions), ANTX (7–47%), and STXs
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(7–35%) [15]. In 2017, researchers Chernova et al. found evidence through PCR and LC-MS/MS
of ANTX in Sestroretskij Razliv Lake, Russia, produced specifically by AFA [62]. Environmental
conditions as well as bloom composition should be monitored closely due to the potential for changes
in toxicity under increases in sunlight and temperature. Mariani et al. discovered that AFA and
Aphanocapsa spp. dominated total CyanoHABs during periods of maximum MC concentration in
Sardina, Italy [3]. There is still disagreement on whether AFA has the ability to produce cyanotoxins
and this may be dependent upon environmental conditions and location. In 2012, a molecular study
was carried out using 16S rRNA sequencing and results concluded that AFA did not show amplification
for the toxin producing mcyE gene, and did not produce ANTX or STX [48]. Gkelis et al. also supported
this theory of biogeographic toxicity stating that the Aphanizomenon spp. STX gene cluster may be
biogeographically differentiated by county [55]. In Ireland AFA is commonly associated with blooms
that have high MC concentration, but may be attributed to other contaminating species such as
M. aeruginosa or A. gracile [63]. Researchers recommended further studies using molecular detection
methods to determine whether AFA is a MC producer [63].
The first report of CYN in AFA was reported by Preussel et al. in Germany, 2006 through
LC-MS/MS analysis and detection of PCR products of gene fragments [17]. In 2007, Fastner et al. also
reported AFA as a CYN producer using microscopy and mass spectrometry identification methods [28].
CYN production was also reported in France and the Czech Republic where AFA was found to be
a potential producer of CYN due to AFA dominated CyanoHABs where CYN was detected [51,64].
This was not confirmed with molecular detection methods and would be an area for future research.
Ferreira et al. (2001) was the first report of STX toxins GTX4, GTX1, GTX3 [53]. This was followed
in 2006 by Liu et al. who first reported STXs among AFA isolates discovered in China, through
HPLC-FLD and LC-MS detection methods [8]. Among dietary supplements, the toxin-producing mcyA
gene was detected in all AFA dietary supplements tested, which could be attributed to contamination
by other toxic cyanobacteria such as Microcystis spp. [59]. Similarly, in 2012 Heussner et al. found all
AFA products in their study tested positive for MCs and the mcyE gene [11].
The evidence for production of ANTX, CYN, MC, and STX, by AFA is of increasing concern,
given that AFA occurs with high frequency in freshwater ecosystems throughout the U.S., and is
regularly and increasingly used as a dietary supplement. Not only is AFA abundant in CyanoHAB
events, but it appears to survive well in poor growth conditions as well, even at low temperatures [5].
AFA production of CYN and ANTX still remains uncertain [15]. Apart from AFA, the remaining seven
Aphanizomenon spp. of this genus have only been described morphologically [15]. No phylogenetic
data are available which can support their assignment to the genus Aphanizomenon and distinguish
them as separate species [15]. AFA may have seasonality and/or biogeographical requirements for
toxin production which should be established in order to confirm safety of both recreational water use
and dietary supplements.
One finding of this review is the large amount of uncertainty that exists over the potential for AFA
to carry toxin genes and produce toxins. Several earlier studies have misidentified Aphanizomenon spp.
for AFA and therefore their findings cannot be confirmed or used as evidence to support the presence of
toxin production by AFA [32,65]. Without proper species identification, it is impossible to tell whether
the cyanobacteria are AFA, or another species of Aphanizomenon such as A. gracile, which is a known
toxin producer [15,66]. In addition, the data are currently insufficient to develop solid quantitative
recreational values for cyanobacterial cell densities related to negative health outcomes [67]. Previous
studies by Heinze et al. 1999 [40] and Humpage and Falconer in 2003 [37], have served as references
for WHO, EPA and the Oregon Health Authority [58] to develop RfD for MCs and CYN toxins.
No current NOAELs exist for ANTX or STX toxins, therefore TDI and guideline values cannot be
properly assessed at this time. Because exposures can be acute (e.g., drinking water), sub-acute
(e.g., recreational swimming exposure), and chronic (e.g., dietary supplement use), a single guideline
value for any cyanotoxins is not appropriate [5]. Rather, it is recommended that a series of guideline
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values associated with incremental severity and probability of health effects should be defined at all
three levels (acute, sub-acute, and chronic) [5].
4. Conclusions
Cyanobacteria blooms are commonly a mixture of toxic and non-toxic genotypes, and associated
toxin concentrations can be highly variable both spatially and temporally [52,68]. Additionally, there is
evidence that AFA carries toxin genes and produces significant levels of CYN and STX [17,28,50,51,69].
These toxins can potentially harm people, pets, livestock, aquatic animals, birds and other wildlife.
In past analysis of AFA supplements, researchers have found the presence of a multitude of toxins
including ANTX, STX, CYN, BMAA and MC [11]. MCs have been identified as the most common
contaminants of BGAS [9,11]. Uncertainty remains regarding whether AFA was properly identified in
earlier studies and was even reclassified to unidentified species of Aphanizomenon in two studies [32,65].
AFA-based BGAS may be contaminated with other more toxigenic species of Aphanizomenon or
M. aeruginosa [10,41,59]. Overall, all studies looking more broadly at Aphanizomenon spp. have shown
a moderate to high production of toxins.
The presence of toxins in recreational waters and BGAS production environments remains a public
health concern when CyanoHABs are present, with elevated levels of MCs being found and increasing
reports of illness. Accumulated evidence from the peer-reviewed literature suggests that AFA carries
toxigenic genes and has the potential to produce toxins under the right environmental conditions.
Toxin production of cyanobacteria is highly variable, both within and between blooms and given
the timing or seasonality of the bloom [52]. Evidence for production of ANTX, CYN, MC and STX by
AFA is of immediate concern, given that AFA occurs with high frequency in freshwater ecosystems
throughout the U.S. and is regularly and increasingly used as a dietary supplement. This issue should
be evaluated regardless of the species of Aphanizomenon due to the potential for cross-contamination
among species, and lack of regulation and testing among dietary supplements. Further investigation
is warranted to improve our understanding of the effects that AFA dietary supplements have on
consumers [57]. Surveys isolating individual colonies of Microcystis spp. from Upper Klamath
Lake should be followed by laboratory cultivation and subsequent toxicological analyses to provide
information on the toxicity of cyanobacterial contaminants [59].
The following recommendations are based on the most current global studies (2000–2017) to
inform public health, regulatory and natural resource management agencies regarding AFA toxicity to
make the most informed decisions.
4.1. Recommendation to Post Educational Signs as a Precautionary Measure at First Sight of Visible Scum
These signs will help to educate and alert the public of the potential health risks associated with
recreational water use during CyanoHABs. This step is particularly important for recreational users
with small children or dogs. It is recommended that signs be posted at first visual confirmation of
scum, while cell counts and/or toxicity analyses are underway. This action would reduce the risk of
exposure to cyanotoxins.
4.2. Recommendation to Limit Harvesting of AFA to Months When Toxicity Is Lowest
The majority of studies indicate that cyanobacteria produce most toxins under environmental
conditions, which are most favorable for their growth (warmer summer months). When temperature
and light requirements are optimal for toxin production, AFA may produce more MCs than during
times with less than optimal temperature and light [5]. This may lead to recommendations for seasonal
harvesting of AFA when MC concentration would be lowest, and for increased testing and warnings
for BGAS production and recreational use during times of high MC levels. This action would reduce
global risk of exposure to humans and domestic animals from BGAS contamination with cyanotoxins.
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4.3. Recommendation to Include AFA in Cell Counts during Visible Blooms
It has been demonstrated that AFA has the potential to produce toxins, and should be included
in the cell counts of toxigenic cyanobacteria for public health advisories related to CyanoHABs.
Ending exclusion of AFA from CyanoHAB advisory criteria would lead to increased frequency and
duration of public health advisories and would reduce the risk of exposure to cyanotoxins. This may
be evaluated and revised after additional evidence.
4.4. Recommendation to Reduce Health Advisory Guideline Value for Cyanotoxin Levels
The EPA’s cyanotoxin guidelines were established under scientific rigor based on existing
knowledge from published peer-reviewed scientific evidence on the adverse human health effects
of toxins, criteria methodologies, and recreation-specific exposure parameters, reviewed by the
Health and Ecological Criteria Division, Office of Science and Technology Office of Water, U.S. [14].
The health advisory guideline value for MCs should be reduced to match EPA’s proposed guidelines
of 4 µg/ L [67]. Adoption of the EPA’s values as recreational use and swimming advisory values at
the state level should be adopted under CWA 303(c) as ambient water quality standards. Addition of
cyanotoxin water quality standards would eventually improve water quality and reduce exposure risks.
4.5. Recommendations for Proper Species Identification Using 16S rRNA Methods When Toxicity Levels Are
Higher than Advisory Levels
Prior to 2007, several research studies had misidentified another toxin-producing cyanobacteria
species for AFA. Previous attempts to differentiate toxigenic from non-toxic strains of the same species
using microscopic methods have failed. Therefore, it is not recommended to identify species of
cyanobacteria using only microscopic methods. During CyanoHABs events when cyanotoxin levels
are above health advisory guideline values, advanced molecular methods such as 16S rRNA PCR
should be used to determine specific strains of toxigenic cyanobacteria. This information would help
to focus analysis for cyanotoxins and inform future evaluation of cyanobacteria toxigenicity.
4.6. Recommendations for Laboratory-Based Research to Confirm the Ability of AFA to Produce Toxins under
Differing Environmental Conditions
Further research would provide an evidence base to improve recommendations for recreational and
BGAS guidance values. It should be noted whether there is a visible algal bloom (include picture) at
the time the sample is taken in addition to recording other environmental factors such as temperature
(ambient and water), pH, and whether it is raining/snowing. Protocols for sample collection, preparation
and storage should be evaluated for improvement. Both microscopic evaluation and ELISA testing should
be done regardless of cell count. Cell count and ELISA results should be recorded and compared across
time to note any predictive environmental factors for increased toxicity and to definitively prove whether
AFA is a toxin producer. Molecular techniques should be employed to detect toxicity genes. This work
will help to either confirm or refute the presence of toxin producing genes and better understand the risks
associated with AFA in recreational waters and dietary supplements.
5. Materials and Methods
A systematic review of the peer-reviewed literature was conducted per the preferred reporting
items for systematic review and meta-analysis protocol (PRISMA-P, Figure 1). The PRISMA-P is a
27-item checklist developed to strengthen the methodological quality, assessment of bias and quality
of systematic reviews. No existing review protocols exist for this systematic review [70].
5.1. Search Strategy
A systematic search was conducted using the following electronic databases: NCBI’s PubMed,
Web of Science, Cochrane CEN-TRAL. The following combinations of search terms were used: Toxicity
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and Aphanizomenon flos-aquae, cyanobacteria, harmful algal blooms, Aphanizomenon and toxicity in fresh
waters, lakes, and dietary supplements. Two independent researchers screened titles and abstracts
to identify eligible studies for inclusion within this systematic review. A literature search in NCBI’s
PubMed database for ‘Aphanizomenon flos aquae’ returned 145 articles. Search term ‘Toxicity and
Aphanizomenon flos aquae’ returned 50 articles. Ten more articles were identified using Science Direct
through Oregon State University’s library; these mentioned AFA as being found in CyanoHABs but
did not specifically describe AFA toxigenicity. Three additional review articles were identified through
Cochrane. Articles which did not include measurement of toxin levels, or that did not specifically
evaluate whether AFA was the producer of measured toxins, were excluded. In addition, systematic
reviews were excluded in the analysis, but were considered for background information and article
identification. Articles that included Aphanizomenon spp. were independently evaluated for relatedness.
Titles with keywords “Aphanizomenon, Aphanizomenon flos aquae, toxicity including ATNX, CYN, MC,
STX or PSP toxins, toxigenic, dietary supplements, and/or fresh-water” were included in the review.
All relevant peer-reviewed articles up to 1 August 2017 were considered for inclusion.
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5.2. Inclusion Criteria
Included studies were all peer-reviewed research articles measuring toxin levels and toxigenicity
of AFA either in recreational waters, dietary supplements, or measuring toxicity and/or illness in
either human cases or animal studies. Peer-reviewed articles and published books or reports with an
ISBN number were included. All seventeen articles for inclusion listed in Table 1 referenced directly
measured toxin levels associated with Aphanizomenon spp. dominated blooms or specifically measured
genes and toxin production by AFA.
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Table 1. Characteristics of studies included in the systematic review for AFA toxigenicity (2000–2017).
Lead Author (Year) Location Findings Method of Detection Conclusions
Roy-Lachapelle (2017) Canada
Out of 18 products tested, 8 contained cyanotoxins
at levels exceeding WHO’s TDI. Supplements
containing AFA had MC concentrations between
0.8 and 8.2 µg/g. Low amounts of BMAA
(neurotoxin) were also found.
Lemieux and Adda oxidation. Chemical
derivatization, laser diode thermal desorption,
and liquid chromatography.
Some dietary products could be harmful upon
long-term consumption due to the presence of
cyanotoxins. A critical need exists for better
monitoring for all BGAS, and guidelines for
maximum intake.
Chernova (2017) Russia Aphanizomenon flos-aquae found to produce ANTX inSestroretskij Razliv Lake
PCR and LC-MS/MS and Restriction Fragment
Length Polymorphism (RFLP) analysis
Both dominant species Aphanizomenon flos-aquae and
Dolichospermum planctonicum are ANTX producers.
Cires (2016) Global
Aphanizomenon spp. known toxin producer
specifically: CYN (11–41% of total toxins, up to
58–63% under certain conditions), ANTX (7–47%
of total toxins), and SXTs (7–35% of total toxins)
Literature Review. Although Aphanizomenon spp. are known toxinproducers, the toxigenicity of AFA is still uncertain.
Mariani (2015) Sardinia AFA and Aphanocapsa spp. dominatedtotal cyanobacteria. ELISA, Mass spectrometer.
Species composition during periods of maximum
MC concentration differed from typical in other
Mediterranean sites.
Sulcius (2015) Lithuania/Russia
Concentrations of cyanotoxins in scum materials
increased from ~30~300 fold compared to bloom
samples. AFA comprised ~19% of total
cyanobacteria biomass. The most common
toxin-producing cyanobacteria from Curonian
Lagoon belong to the genera of Aphanizomenon spp.,
Microcystis, and Planktothrix.
Microscopic, and chemical. Extraction of saxitoxins
with 4 mM ammonium formate buffer and
acetonitrile 2:3 ratio, Mass spectrometer, information
dependent acquisition mode, and multiple
reaction monitoring.
Larger concentrations of cyanotoxins were found in
scum compared to blooms.
Dadheech (2014) Germany
Although AFA dominated total phytoplankton at
>80% contribution to total biomass, AFA did not
show amplification for the mcyE gene, or STX and
ANTX production.
Molecular analysis:16S rRNA sequencing,
BLAST identification.
Differences seen in dominant taxon of field sample
from Dolichospermum circinale in 2011 to AFA in 2012,
with reduction in total MC content seen from
27.32 µg/L to 4.25 µg/L.
Gkelis (2014) Greece
C. raciborskii and AFA are potential STX producers.
A. gracile confirmed STX producer. MC: 3.9–108
µg/L, CYNs: 0.3–2.8 µg/L, and STXs: 0.4–1.2 µg/L
Aphanizomenon spp. STX gene cluster may be
biogeographically differentiated by county.
Microscopy, molecular, and immunologic
methods: ELISA.
AFA was not found to be the dominant species in
blooms, or a producer of toxins. Co-occurrence of
more than one cyanotoxins in sites used for drinking
water, agriculture, or recreation represent potential
health risks.
Heussner (2012) Germany
All AFA products tested positive for MCs and the
mcyE gene. The contamination levels of the
MC-positive samples were ≤1 µg MC-LR
equivalents per g dry weight.
Colorimetric protein phosphatase inhibition assay
(cPPIA), Adda-ELISA, Cell Culture,
Liquid chromatography tandem mass spectrometry
(LC-MS/MS), DNA extraction and PCR.
Recommendation for prohibition of marketing and
sale of AFA-based dietary supplements in order to
prevent acute and chronic exposure to MCs.
Mooney (2011) Ireland
AFA, Gomaphosphaeria spp. and Microcystis
aeruginosa were the most dominant cyanobacterial
species associated with high MC concentration. AFA
was dominant in 1/14 sites with lake area of
382 km2, and MC concentration of 1652 ng/µg Chla
Synoptic survey of 14 sites, used high performance
liquid chromatography-tandem mass spectrometry
(HPLC-MS/MS).
Further studies are recommended to use molecular
detection methods to determine whether AFA is a
MC producer. It is unknown which species
produced the toxins, only recorded dominant
cyanobacteria and total toxin per area.
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Table 1. Cont.
Lead Author (Year) Location Findings Method of Detection Conclusions
Blahova (2009) France
CYN was found at 3 localities with Aphanizomenon
spp. sub-dominated water blooms. Concentrations
determined by ELISA (0.4–4 µg/L) were
systematically higher than concentrations
determined by LC/MS (0.01–0.3 µg/L).
ELISA and LC/MS. AFA is a potential producer of CYN.
Brient (2009) Czech Republic
AFA var klebahnii found to be a potential producer of
CYN. Intracellular concentrations of CYN ranged
between 1.55 and 1.95 µg/L.
LC-MS/MS. AFA is a potential producer of CYN.
Palus (2007) Poland
AFA dominated blooms August–October. The
concentration of MC in water did not exceed 1 µg/L,
Cyanobacteria co-occurrence found with E. coli.
Protein phosphatase inhibition assay (PPIA), ELISA
and HPLC.
Phytoplankton biomass and genotoxicity of
CyanoHABs should be assessed to avoid public
health issues.
Fastner (2007) Germany
Concentrations reached up to 73.2 µg CYN/g dry
weight. Study confirmed AFA is a CYN-producing
species frequently inhabiting water bodies in
temperate climatic regions.
Microscopy, Mass-spectrometer.
Aphanizomenon spp. may be an important CYN toxin
producer in Germany waters. A world hazard
analysis and risk assessment is recommended to
confirm by geographic regions.
Saker (2007) Australia and Canada
mcyA gene was detected in all 12 AFA dietary
supplements, suggesting contamination by
Microcystis spp.
Multiplex PCR.
Dietary supplements containing AFA are more at
risk for contamination by Microcystis spp.,
and should be monitored. Laboratory and
toxicological analysis of Upper Klamath Lake
cyanobacteria would provide useful information to
inform and protect human health.
Preussel (2006) Germany Toxin CYN detected in the range of 2.3–6.6 mg/g ofcellular dry weight.
LC-MS/MS analysis and detection of PCR products
of gene fragments. First report of CYN in AFA strains.
Ferreira (2001) Portugal
Presence of PSP toxins: GTX4, GTX1, GTX3, and Cs
toxin present either in cells of AFA or in other
toxic isolates.
High performance liquid chromatography (HPLC)
using 2 isocratic elution systems.
AFA known STX producer, but A. circinalis is also
found to be potential STX producer. More work is
needed to understand the toxicological profiles
of cyanobacteria.
Liu (2006) China
STXs produced by AFA bloom. Significant
glutathione-S-transferase (GST) and lactate
dehydrogenase (LDH) increases, together with
decrease of the glutathione (GSH) level,
were measured.
High performance liquid chromatography with
post-column fluorescence derivatization
(HPLC-FLD) and liquid chromatographic mass
spectrometry technique (LC-MS).
The results indicate a potential role of STXs
intoxicating and metabolizing in test animals.
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5.3. Exclusion Criteria
Articles were excluded if no English abstract was available. Review articles, student theses,
newspapers or magazine reports, commentaries, correspondences, and letters were excluded from
this review. Additionally, articles were excluded if there was no evaluation of toxin levels or direct
human health outcomes due to exposure to AFA in either recreational waters or dietary supplements.
Although two articles were found to be relevant to the search terms, it was later discovered there
was a re-classification of the cyanobacteria from AFA to Aphanizomenon spp. These are considered for
background and discussion but were excluded from the systematic review.
5.4. Study Quality Assessment
For each included study, the quality of evidence was assessed using the GRADE (Grading of
Recommendations: Assessment, Development and Evaluation) method. The GRADE method rates
the quality of evidence presented in research studies for evaluation. Evidence is assessed based
on five factors: risk of bias, imprecisions, inconsistency, indirectness of evidence and publication
bias. The quality of evidence is rated on the following scale: “High Quality”, “Moderate Quality”,
“Low Quality” and “Very Low Quality.” Randomized control trials are considered “High Quality”
evidence but, can be downgraded if there is a serious risk of bias in the study. Additionally, observation
studies begin as “Low Quality” evidence and can be upgraded due to large effect size (Relative
Risk or Odds Ratio > 2), presence of a dose response or the presence of confounders against bias.
The methodology is widely used and accepted by numerous organizations including the WHO.
Articles were assessed, and tables were produced using the online GRADEpro toolkit, summary of
findings table.
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